In addition to the agents mentioned above, exogenous modulation of Eg5 expression (represented by RNA interference (RNAi) technique) is also a promising therapeutic strategy in clinical practice, like Eg5-silencing induces tumor inhibition mediated by the delivery of nano or cationic liposomes coated siRNAs/shRNAs [167]. This evidence concerns the gene KIF11 and neoplasm.